In-depth Notes on E. coli

Overview of Escherichia coli (E. coli)

  • Family: Enterobacteriaceae

  • Commonly Found: In labs, E. coli is recognized as the most prevalent organism.

Infections Caused by E. coli

  • Urinary Tract Infections (UTIs)

    • E. coli is responsible for up to 90% of UTIs, primarily affecting women.

    • Statistics: More than 50% of women experience a UTI in their lifetime; 20%-40% will have recurrent infections.

    • Symptoms:

    • Strong urge to urinate

    • Burning sensation during urination

    • Frequent urination with small output

    • Cloudy or blood-tinged urine

    • Strong-smelling urine

    • Pelvic pain in women

    • Risk Factors:

    • Not drinking enough fluids

    • Frequent baths

    • Prolonged urine retention

    • Presence of kidney stones

  • Gastroenteritis

    • Enterohemorrhagic E. coli (E. coli O157:H7): Associated with bloody diarrhea and potential development of hemolytic uremic syndrome (HUS).

    • Toxins: Produces shiga toxins, leading to severe illness.

    • Enterotoxigenic E. coli: Known for causing watery diarrhea (also referred to as traveller's diarrhea or Montezuma's revenge).

    • Enteropathogenic E. coli: Causes diarrhea particularly in infants, especially in developing countries.

Shiga-toxin Producing E. coli (STEC)

  • Characterization:

    • O Antigen: Somatic antigen on the cell wall.

    • H Antigen: Flagellar antigen.

  • Transmission:

    • Often found in undercooked contaminated meats (e.g., ground beef) and unwashed produce.

  • Symptoms of STEC Infection:

    • Severe stomach cramps

    • Diarrhea (often bloody)

    • Vomiting

    • Low-grade fever

    • Potential development of HUS in 5-10% of cases, leading to kidney failure, particularly in children.

  • Diagnosis in Laboratories:

    • STEC is identified by its inability to ferment sorbitol, distinguished using MacConkey with Sorbitol agar.

Rising Concerns in Drug Resistance

  • Extended Spectrum Beta-Lactamases (ESBL)

    • Some E. coli and Klebsiella species have developed ESBLs, leading to resistance against a range of penicillin antibiotics.

  • Treatment:

    • Carbapenems are currently considered the treatment of choice for infections caused by resistant organisms.

    • Carbapenem Resistant Enterobacteriaceae (CRE): An increasing concern, primarily associated with healthcare settings, resulting in severe opportunistic infections (e.g., pneumonia, bloodstream infections, meningitis).

Benefits of E. coli

  • Role in Digestion: Aids in the digestive process in the gut.

  • Protection: Helps protect against harmful microbes.

  • Vitamin Production: Synthesizes vitamins B12 and K.

  • Iron Uptake: Produces enterobactin, facilitating iron absorption.

  • Research and Biotechnology: Historically served as a key model organism in molecular biology and biotechnology, crucial for the production of recombinant proteins (e.g., insulin, cancer treatments).